Glycoside derivative and uses thereof

Details for Australian Patent Application No. 2010309788 (hide)

Owner Novartis AG

Inventors Bebernitz, Gregory Raymond; Bock, Mark G.; Bhuniya, Debnath; Datrange, Laxmikant; Kurhade, Suresh Eknath; Palle, P. Venkata; Reddy, Dumbala Srinivas

Agent Davies Collison Cave

Pub. Number AU-A-2010309788

PCT Pub. Number WO2011/048148

Priority 2172/DEL/2009 20.10.09 IN

Filing date 20 October 2010

Wipo publication date 28 April 2011

International Classifications

C07D 309/10 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

A61K 31/351 (2006.01) - not condensed with another ring

A61K 31/7034 (2006.01)

A61K 31/7042 (2006.01) - Compounds having saccharide radicals and heterocyclic rings

A61K 31/7056 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 309/30 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

C07D 405/10 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 407/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 407/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 491/107 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 493/10 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07H 15/203 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

C07H 15/26 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

C07H 17/00 (2006.01) Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

C07H 19/04 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

Event Publications

5 April 2012 PCT application entered the National Phase

  PCT publication WO2011/048148 Priority application(s): WO2011/048148

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010309808-Biomarker for diagnosis, prediction and/ or prognosis of acute heart failure and uses thereof

2010309784-Composition comprising Solanum glaucophyllum for preventing and/or treating hypocalcaemia and for stabilizing blood calcium levels